BMC Gastroenterology · 2025 · 18 citations · 25 references
Veterinary MedicineGeriatric MedicineAgingEpidemiologic MethodsInflammationBiomarkers Of Liver InjuryChronic Liver DiseaseCirrhosisInflammatory BiomarkersLiver DiseaseMetabolic Liver DiseaseBiomarkersCross-sectional EpidemiologyLiver BiomarkersMetabolic Disease BiomarkersRestricted Cubic Spline Models
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a primary cause of chronic liver disease, with potential progression to cirrhosis and hepatocellular carcinoma (HCC). Although systemic inflammatory biomarkers are associated with liver diseases, their specific role in MASLD remains unclear. This study examines the association between systemic inflammatory biomarkers and MASLD. METHODS: This cross-sectional study enrolled 6613 adults aged 20 years or older from the National Health and Nutrition Examination Survey (NHANES) spanning from 2017 to March 2020. Among these participants,, 34.67% were aged 40-59 years, 50.85% were female, and 63.26% were Non-Hispanic White. We investigated 10 inflammatory biomarkers: ALI, SIRI, SII, SIPS, IBI, NLR, PLR, CAR, LMR, and PNI. Logistic regression models were performed to assess the linear association between systemic inflammatory biomarkers and MASLD. Restricted cubic spline (RCS) regression was employed to explore potential nonlinear relationships between biomarkers and MASLD risk. Additionally, subgroup analyses were conducted to examine the influence of various demographic and clinical characteristics on the observed associations. RESULTS: After adjusting for key confounders, NLR and PLR exhibited negative association with MASLD risk, while ALI, CAR, and PNI exhibited the opposite association (P < 0.05). Most biomarkers, including ALI, SIRI, IBI, CAR, LMR, and PNI, exhibited significant non-linear correlations with MASLD (P < 0.05). Subgroup analyses revealed substantial age-related differences in the association between ALI and MASLD risk, as well as varying relationships between PNI and MASLD risk across various cardiovascular outcomes (P < 0.05). CONCLUSION: Systemic inflammatory biomarkers are significantly associated with MASLD risk. Large-scale prospective studies are warranted to confirm these findings and elucidate the underlying mechanisms.
25
Mohammad Shadab Siddiqui, Raj Vuppalanchi, Mark L. Van Natta et al. · Clinical Gastroenterology and Hepatology · 2018 · 594 citations · Full text
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong · Hepatology · 2024 · 139 citations · Full text
C-reactive protein: structure, function, regulation, and role in clinical diseases
Haihong Zhou, Yulong Tang, Tianhao Xu et al. · Frontiers in Immunology · 2024 · 112 citations · Full text